Close

Analyst Ratings for Aimmune Therapeutics (AIMT) [Neutrals]

All Latest Ratings for AIMT

AIMT Rating Summary

  |   Expand Research on AIMT
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.8 / 10   Percentile Rank: 36%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/1/2020 Cantor Fitzgerald Charles Duncan Downgrade Neutral
(Buy)		 35.00
(N/A)		 12.60
(34.49)		 173.73% Details
9/1/2020 Wedbush Liana Moussatos Downgrade Neutral
(Outperform)		 34.50
(66.00)		 12.60
(34.49)		 173.73% Details